| 101 |
25736303 | Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. | 2015 Dec |
1 |
| 102 |
25965911 | PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer. | 2015 Jun 10 |
1 |
| 103 |
26187504 | APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma. | 2015 Oct |
1 |
| 104 |
26188124 | A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. | 2015 Sep 15 |
1 |
| 105 |
26208523 | The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. | 2015 Oct |
1 |
| 106 |
26222289 | Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells. | 2015 Mar |
1 |
| 107 |
26368019 | Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation. | 2015 |
3 |
| 108 |
26425688 | TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients. | 2015 Aug |
3 |
| 109 |
26459801 | Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. | 2015 Dec |
2 |
| 110 |
24052409 | Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma. | 2014 Jan |
1 |
| 111 |
24277474 | Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy. | 2014 Feb |
1 |
| 112 |
24434574 | Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma. | 2014 Jan |
1 |
| 113 |
24462821 | Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy. | 2014 May 1 |
4 |
| 114 |
24504010 | Alteration of gene expression and DNA methylation in drug-resistant gastric cancer. | 2014 Apr |
1 |
| 115 |
24587255 | A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines. | 2014 |
6 |
| 116 |
24634414 | Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. | 2014 May |
2 |
| 117 |
24712391 | Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. | 2014 Aug 4 |
1 |
| 118 |
24733045 | JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy. | 2014 Apr 15 |
6 |
| 119 |
24801380 | Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells. | 2014 Aug |
1 |
| 120 |
24846461 | Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells. | 2014 |
1 |
| 121 |
25135238 | The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. | 2014 Nov |
1 |
| 122 |
25401416 | Cooperative interactions between p53 and NFκB enhance cell plasticity. | 2014 Dec 15 |
1 |
| 123 |
25788859 | Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. | 2014 |
1 |
| 124 |
22841540 | Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. | 2013 Apr |
2 |
| 125 |
22963136 | Possible predictive value of maspin expression in colorectal cancer. | 2013 May |
2 |
| 126 |
23076534 | Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells. | 2013 Feb |
2 |
| 127 |
23108402 | 5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells. | 2013 Sep 19 |
4 |
| 128 |
23423487 | Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy. | 2013 Apr |
4 |
| 129 |
23441616 | Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. | 2013 |
3 |
| 130 |
23456958 | The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer. | 2013 Sep 15 |
1 |
| 131 |
23727578 | Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53. | 2013 Jun 28 |
4 |
| 132 |
23729362 | Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy. | 2013 Jul 15 |
2 |
| 133 |
23810214 | A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. | 2013 Sep |
1 |
| 134 |
23837948 | Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway. | 2013 Dec |
1 |
| 135 |
23936455 | TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. | 2013 |
1 |
| 136 |
21706156 | MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide. | 2012 Apr |
2 |
| 137 |
21713761 | FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. | 2012 Jan 1 |
1 |
| 138 |
22192357 | 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation. | 2012 Jan 20 |
2 |
| 139 |
22213289 | Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells. | 2012 Jan |
1 |
| 140 |
22286760 | Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1. | 2012 Dec 6 |
7 |
| 141 |
22441128 | Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo. | 2012 May 15 |
10 |
| 142 |
22445862 | Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element. | 2012 Aug |
3 |
| 143 |
22525470 | Different responses to 5-fluoraouracil in mutagenicity and gene expression between two human lymphoblastoid cell lines with or without TP53 mutation. | 2012 |
2 |
| 144 |
22607196 | Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. | 2012 Aug |
1 |
| 145 |
22684338 | Prospective impact of 5-FU in the induction of endoplasmic reticulum stress, modulation of GRP78 expression and autophagy in Sk-Hep1 cells. | 2012 Sep |
1 |
| 146 |
22716215 | Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration. | 2012 Jul |
1 |
| 147 |
22790872 | Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. | 2012 Dec |
5 |
| 148 |
22983008 | The transcription factor CREBZF is a novel positive regulator of p53. | 2012 Oct 15 |
1 |
| 149 |
23235459 | PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage. | 2012 Dec 13 |
3 |
| 150 |
20425122 | Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells. | 2011 Feb |
6 |